Intellia Therapeutics stock tumbles on dilutive offering

Chronological Source Flow
Back

AI Fusion Summary

Intellia Therapeutics shares fell sharply after announcing a dilutive offering, while Syntec Optics shares dropped following the pricing of a $20 million stock offering, reflecting investor concerns over dilution in the market.
29/04 14:12 investing.com
3 Πηγές
29/04 14:38 investing.com
29/04 15:02 investing.com
Comments
Loading...
0